Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3G Biotech is a specialized biotechnology company based in India that focuses on the research, development, and large-scale manufacturing of probiotics, enzymes, and nutraceutical ingredients. The company operates a state-of-the-art fermentation facility and provides high-quality microbial strains for pharmaceutical, food, and agricultural applications. Their product portfolio includes well-characterized probiotic strains such as Bacillus clausii and Saccharomyces boulardii, which are used to address various gastrointestinal health issues. In addition to its own product line, 3G Biotech serves as a contract manufacturing partner for global pharmaceutical and healthcare companies. The company is committed to advancing microbial science to improve human health through evidence-based nutritional and therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3G.